India  

Covaxin gets nod for trial of booster shot

IndiaTimes Saturday, 3 April 2021 ()
0
shares
ShareTweetSavePostSend
 

You Might Like


💡 newsR Knowledge: Other News Mentions

BBV152 BBV152 Vaccine against COVID-19

Covaxin production to be increased to 100 million doses per month by September 2021: Centre

Union health minister Harsh Vardhan said financial support is being provided to four manufacturers to expand Covaxin vaccine production.
DNA

India to increase Covaxin production to 100 million doses per month by September

The Union government on Friday said it will amp up the production of the indigenously developed Covaxin vaccine to 100 million doses per month by September. As..
IndiaTimes
Mumbai's Haffkine Institute gets Centre's nod to produce Covaxin [Video]

Mumbai's Haffkine Institute gets Centre's nod to produce Covaxin

The Central Government has given permission to Haffkine Institute to produce Bharat Biotech's Covaxin. CM Uddhav Thackeray thanked PM Modi through a tweet by CM office, Maharashtra on April 15, "The Dept of Science and Technology, Government of India, has granted approval to Haffkine Institute to produce Bharat Biotech's Covaxin vaccine on a transfer of technology basis. CM Uddhav Balasaheb Thackeray has thanked the Hon'ble PM Shri@narendramodi for approving this request."

Credit: ANI    Duration: 01:14Published

Related videos from verified sources

Daily Covid-19 Minute: Moderna Booster [Video]

Daily Covid-19 Minute: Moderna Booster

Vaccine manufacturers have been working to increase efficacy against the new covid variants emerging across the globe including Moderna, who has just announced the start of a new trial to test a..

Credit: CBS 62 Detroit     Duration: 00:56Published

Related news from verified sources

Third dose of Covaxin gets nod for trials, six months after 2nd shot


Indian Express